Premier Perspectives The blog for insider insights in clinical development Patient and Stakeholder Engagement AD Trials: Three routes to increasing enrollment By Sebastian Turek January 18, 2018 Featured Posts Study Design AD Trials: Is your protocol asking the right questions? By Sebastian Turek December 10, 2017 Clinical ResearchPhase 1 - Phase 4 Global Alzheimer’s Disease Trials: 10 Factors to Consider By Sebastian Turek November 29, 2017 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Patient and Stakeholder Engagement 3 of the Hardest Obstacles We Face in Alzheimer’s Clinical Drug Trials By Sebastian Turek October 9, 2017 ×
